[MPI] YoY Annualized Quarter Result on 31-Dec-2017 [#2]

Stock
[MPI] MALAYSIAN PACIFIC INDUSTRIES
Announcement Date
29-Jan-2018
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2018
Quarter
31-Dec-2017 [#2]
Profit Trend
QoQ- 6.84%
YoY- -18.22%
Quarter Report
Latest QR
Upcoming QR
MPI's Result
MPI's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 1,849,040 1,565,720 1,623,836 1,565,772 1,518,836 1,532,676 1,332,028 5.61%
PBT 328,370 229,574 246,820 224,046 270,838 200,714 124,066 17.59%
Tax -34,526 -35,676 -41,114 -38,780 -37,302 4,148 -28,698 3.12%
NP 293,844 193,898 205,706 185,266 233,536 204,862 95,368 20.60%
-
NP to SH 244,690 163,780 163,006 154,886 189,404 159,706 87,942 18.57%
-
Tax Rate 10.51% 15.54% 16.66% 17.31% 13.77% -2.07% 23.13% -
Total Cost 1,555,196 1,371,822 1,418,130 1,380,506 1,285,300 1,327,814 1,236,660 3.89%
-
Net Worth 1,559,420 1,324,690 1,250,239 1,170,319 1,071,182 951,625 795,502 11.86%
Dividend
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Div 39,579 38,011 38,001 37,997 30,388 30,391 26,580 6.85%
Div Payout % 16.18% 23.21% 23.31% 24.53% 16.04% 19.03% 30.22% -
Equity
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Net Worth 1,559,420 1,324,690 1,250,239 1,170,319 1,071,182 951,625 795,502 11.86%
NOSH 209,884 209,884 209,884 209,884 209,884 189,945 189,857 1.68%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 15.89% 12.38% 12.67% 11.83% 15.38% 13.37% 7.16% -
ROE 15.69% 12.36% 13.04% 13.23% 17.68% 16.78% 11.05% -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 934.35 823.82 854.62 824.15 799.70 806.90 701.59 4.88%
EPS 123.86 86.18 85.78 81.54 99.72 84.08 46.32 17.79%
DPS 20.00 20.00 20.00 20.00 16.00 16.00 14.00 6.11%
NAPS 7.88 6.97 6.58 6.16 5.64 5.01 4.19 11.09%
Adjusted Per Share Value based on latest NOSH - 209,884
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 880.98 745.99 773.68 746.02 723.65 730.25 634.65 5.61%
EPS 116.58 78.03 77.66 73.80 90.24 76.09 41.90 18.57%
DPS 18.86 18.11 18.11 18.10 14.48 14.48 12.66 6.86%
NAPS 7.4299 6.3115 5.9568 5.576 5.1037 4.5341 3.7902 11.86%
Price Multiplier on Financial Quarter End Date
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 -
Price 25.96 11.44 9.95 12.62 7.41 9.31 4.53 -
P/RPS 2.78 1.39 1.16 1.53 0.93 1.15 0.65 27.37%
P/EPS 21.00 13.28 11.60 15.48 7.43 11.07 9.78 13.56%
EY 4.76 7.53 8.62 6.46 13.46 9.03 10.23 -11.96%
DY 0.77 1.75 2.01 1.58 2.16 1.72 3.09 -20.65%
P/NAPS 3.29 1.64 1.51 2.05 1.31 1.86 1.08 20.38%
Price Multiplier on Announcement Date
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 25/02/21 26/02/20 21/02/19 29/01/18 25/01/17 28/01/16 22/01/15 -
Price 38.00 11.20 10.22 11.24 7.95 8.66 5.50 -
P/RPS 4.07 1.36 1.20 1.36 0.99 1.07 0.78 31.66%
P/EPS 30.73 13.00 11.91 13.79 7.97 10.30 11.87 17.16%
EY 3.25 7.69 8.39 7.25 12.54 9.71 8.42 -14.65%
DY 0.53 1.79 1.96 1.78 2.01 1.85 2.55 -23.01%
P/NAPS 4.82 1.61 1.55 1.82 1.41 1.73 1.31 24.22%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment